Lin Y. Shi
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Icaritin Inhibits Malignant Progression and Enhances Ferroptosis and Bortezomib Sensitivity by Suppressing HSP90AA1 Expression in Multiple Myeloma.
Journal: Chemical biology & drug design
Published: July 31, 2025
Significance of HALP Score as a Prognostic Indicator for Newly Diagnosed Multiple Myeloma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: May 06, 2025
CAR-T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance status.
Journal: American journal of hematology
Published: December 26, 2021
Synthesis, crystal structure and luminescence properties of a new samarium borate phosphate, CsNa2Sm2(BO3)(PO4)2.
Journal: Acta crystallographica. Section C, Structural chemistry
Published: September 14, 2020
A novel stibium phosphate, LiBa(SbO)2(PO4)3: synthesis, crystal structure and RE3+-activated (RE = Tb3+ and Eu3+) fluorescence performance.
Journal: Acta crystallographica. Section C, Structural chemistry
Published: April 11, 2019
Scutellarein selectively targets multiple myeloma cells by increasing mitochondrial superoxide production and activating intrinsic apoptosis pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 30, 2018
Clinical Analysis of Autologous Cytokine-induced Killer Cells Combined with IL-2 for Treating of Elderly Patients with B-cell Malignant Lymphoma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 26, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026